Trials / Completed
CompletedNCT02646995
Lipid Formulation to Increase the Bioavailability of Fatty Acids in Cystic Fibrosis (CF) Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 5 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to evaluate if the use of a newly developed lipid formulation versus fish oil would better enable the absorption of essential fatty acids after 12 weeks of supplementation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | modified lipid formulation | Tested oils will be used in liquid form and encapsulated in soft gelatin capsules. |
| DIETARY_SUPPLEMENT | Fish oil | Fish oil will be used in liquid form and encapsulated in soft gelatin capsules. |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-03-27
- Completion
- 2017-05-04
- First posted
- 2016-01-06
- Last updated
- 2018-06-06
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02646995. Inclusion in this directory is not an endorsement.